These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5772863)

  • 1. Hypoglycemia activity and toxicity of 4-isoxazolylpyridinium salts and phenformin in normal mice.
    Blickens DA; Riggi SJ
    Toxicol Appl Pharmacol; 1969 Mar; 14(2):393-400. PubMed ID: 5772863
    [No Abstract]   [Full Text] [Related]  

  • 2. Some effects of 1-methyl-4-(3-methyl-5-isoxazolyl) pyridinium chloride and phenformin on carbohydrate and lipid metabolism in mice.
    Blickens DA; Riggi SJ
    Diabetes; 1969 Sep; 18(9):612-8. PubMed ID: 5821059
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoxazolylpyridinium salts. A new class of hypoglycemic agents.
    Bauer VJ; Fanshawe WJ; Dalalian HP; Safir SR
    J Med Chem; 1968 Sep; 11(5):984-6. PubMed ID: 5697111
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbohydrate metabolism in normal and hyperglycemic animals treated with 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride and phenformin.
    Blickens DA; Riggi SJ
    J Pharmacol Exp Ther; 1971 Jun; 177(3):536-45. PubMed ID: 5568809
    [No Abstract]   [Full Text] [Related]  

  • 5. 4-Azolylpyridine 1-oxides. Analogs of the hypoglycemic 4-azolylpyridinium salts.
    Bauer VJ; Fanshawe WJ; Wiegand GE; Safir SR
    J Med Chem; 1969 Sep; 12(5):945-6. PubMed ID: 5812231
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoglycemic quaternary azolylpyridinium salts. Inactive analogs.
    Bauer VJ; Wiegand GE; Fanshawe WJ; Safir SR
    J Med Chem; 1969 Sep; 12(5):944-5. PubMed ID: 5812230
    [No Abstract]   [Full Text] [Related]  

  • 7. Quaternary oxazolylpyridinium salts. Oral hypoglycemic agents.
    Wiegand GE; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1969 Sep; 12(5):943-4. PubMed ID: 5812229
    [No Abstract]   [Full Text] [Related]  

  • 8. Mode of action of hypoglycemic agents. IV. Control of the hypoglycemic activity of phenethylbiguanide in rats and guinea-pigs.
    Cook DE; Blair JB; Gilfillan C; Lardy HA
    Biochem Pharmacol; 1973 Sep; 22(17):2121-8. PubMed ID: 4733667
    [No Abstract]   [Full Text] [Related]  

  • 9. A new oral hypoglycemia agent: 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride.
    Riggi SJ; Blickens DA; Boshart CR
    Diabetes; 1968 Oct; 17(10):646-7. PubMed ID: 5681081
    [No Abstract]   [Full Text] [Related]  

  • 10. Quaternary thiazolylpyridinium salts. Oral hypoglycemic agents.
    Wiegand GE; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1969 Sep; 12(5):891-3. PubMed ID: 5812206
    [No Abstract]   [Full Text] [Related]  

  • 11. 1,2,4-Oxadiazolylpyridinium salts. Oral hypoglycemic agents.
    Fanshawe WJ; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1969 May; 12(3):381-3. PubMed ID: 5788149
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of gene expression changes induced by biguanides in db/db mice liver.
    Heishi M; Hayashi K; Ichihara J; Ishikawa H; Kawamura T; Kanaoka M; Taiji M; Kimura T
    J Toxicol Sci; 2008 Aug; 33(3):339-47. PubMed ID: 18670165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lack of concordance in the effect of large doses of phenformin on insulin secretion and glycemia. Tentative analysis].
    Ribes G; Valette G; Lignon F; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1977; 171(4):870-5. PubMed ID: 145295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quaternary furyl-, thienyl-, and pyrrolylpyridinium salts. Oral hypoglycemic agents.
    Wiegand GE; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1971 Mar; 14(3):214-5. PubMed ID: 5552211
    [No Abstract]   [Full Text] [Related]  

  • 15. Quaternary 4- (and 5-) azolylpyridazinium salts. A new class of oral hypoglycemic agents.
    Wiegand GE; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1972 Dec; 15(12):1326-8. PubMed ID: 4635983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypoglycemic activity and tolerance of glibenclamide-phenformin association].
    Fanelli O; Bianchi G; Fascetti P; Trallori L
    Boll Chim Farm; 1971 Aug; 110(8):470-8. PubMed ID: 5002955
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetics of blood glucose lowering biguanide derivatives].
    Mehnert H
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():137-42. PubMed ID: 4906018
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of phenformin hydrochloride on pharmacokinetics of puerarin in rats].
    Deng Y; Li N; Cui M; Xiong ZL; Li FM
    Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(19):2960-3. PubMed ID: 23270242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaternary indolylpyridinium salts. Oral hypoglycemic agents.
    Fanshawe WJ; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1970 Sep; 13(5):993-5. PubMed ID: 5458403
    [No Abstract]   [Full Text] [Related]  

  • 20. Teicoplanin does not modify the hypoglycemic effects of phenformin or glibenclamide, nor the anticoagulant action of warfarin. Experimental study.
    Rossi F; Marrazzo R; Lucarelli C; Marabese I; De Santis D
    J Chemother; 1991 Jun; 3(3):152-5. PubMed ID: 1833514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.